Vibol Tan

Array ( [id] => 1502320 [patent_doc_number] => 06464972 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Recombinant poliovirus for the treatment of cancer' [patent_app_type] => B1 [patent_app_number] => 09/566581 [patent_app_country] => US [patent_app_date] => 2000-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 40 [patent_no_of_words] => 15979 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/464/06464972.pdf [firstpage_image] =>[orig_patent_app_number] => 09566581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253016 [patent_doc_number] => 06670114 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-30 [patent_title] => 'Host derived proteins binding HCV: medical, diagnostic and purification use' [patent_app_type] => B1 [patent_app_number] => 09/564951 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 12718 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670114.pdf [firstpage_image] =>[orig_patent_app_number] => 09564951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1271735 [patent_doc_number] => 06653464 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Methods and compositions for screening for human Borna disease virus' [patent_app_type] => B1 [patent_app_number] => 09/563456 [patent_app_country] => US [patent_app_date] => 2000-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 44 [patent_no_of_words] => 36609 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653464.pdf [firstpage_image] =>[orig_patent_app_number] => 09563456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1370301 [patent_doc_number] => 06562599 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Single-stranded antibody against hepatitis B virus core protein, gene thereof, and therapeutic agent for hepatitis B containing these' [patent_app_type] => B1 [patent_app_number] => 09/486814 [patent_app_country] => US [patent_app_date] => 2000-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 13465 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562599.pdf [firstpage_image] =>[orig_patent_app_number] => 09486814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6744972 [patent_doc_number] => 20030022155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Method for detecting hepatitis c virus with hybridomas' [patent_app_type] => new [patent_app_number] => 09/549685 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5024 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022155.pdf [firstpage_image] =>[orig_patent_app_number] => 09549685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1290823 [patent_doc_number] => 06630343 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Hepatitis C virus culture system' [patent_app_type] => B1 [patent_app_number] => 09/539601 [patent_app_country] => US [patent_app_date] => 2000-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 17315 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630343.pdf [firstpage_image] =>[orig_patent_app_number] => 09539601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1333014 [patent_doc_number] => 06592874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-15 [patent_title] => 'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis' [patent_app_type] => B2 [patent_app_number] => 09/507362 [patent_app_country] => US [patent_app_date] => 2000-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 68 [patent_no_of_words] => 70690 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/592/06592874.pdf [firstpage_image] =>[orig_patent_app_number] => 09507362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720299 [patent_doc_number] => 20030053987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'SYNTHETIC HEPATITIS C GENES' [patent_app_type] => new [patent_app_number] => 09/194949 [patent_app_country] => US [patent_app_date] => 2000-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 5951 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20030053987.pdf [firstpage_image] =>[orig_patent_app_number] => 09194949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391134 [patent_doc_number] => 06541198 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Antibodies and other binding molecules specific for hepatitis B viral antigens' [patent_app_type] => B1 [patent_app_number] => 09/446787 [patent_app_country] => US [patent_app_date] => 2000-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10253 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541198.pdf [firstpage_image] =>[orig_patent_app_number] => 09446787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380692 [patent_doc_number] => 06551820 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Expression of immunogenic hepatitis B surface antigens in transgenic plants' [patent_app_type] => B1 [patent_app_number] => 09/471573 [patent_app_country] => US [patent_app_date] => 1999-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 42 [patent_no_of_words] => 32612 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/551/06551820.pdf [firstpage_image] =>[orig_patent_app_number] => 09471573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1489789 [patent_doc_number] => 06416946 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Methods of typing hepatitis C virus and reagents for use therein' [patent_app_type] => B1 [patent_app_number] => 09/437895 [patent_app_country] => US [patent_app_date] => 1999-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9007 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/416/06416946.pdf [firstpage_image] =>[orig_patent_app_number] => 09437895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1468956 [patent_doc_number] => 06406695 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Treatment of hepatitis C by administration of anti-IL-2 receptor monoclonal antibody' [patent_app_type] => B1 [patent_app_number] => 09/429936 [patent_app_country] => US [patent_app_date] => 1999-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3084 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/406/06406695.pdf [firstpage_image] =>[orig_patent_app_number] => 09429936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1230956 [patent_doc_number] => 06692908 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor' [patent_app_type] => B1 [patent_app_number] => 09/430489 [patent_app_country] => US [patent_app_date] => 1999-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17821 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692908.pdf [firstpage_image] =>[orig_patent_app_number] => 09430489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1466746 [patent_doc_number] => 06458560 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis' [patent_app_type] => B1 [patent_app_number] => 09/415868 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 68 [patent_no_of_words] => 70843 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458560.pdf [firstpage_image] =>[orig_patent_app_number] => 09415868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1458471 [patent_doc_number] => 06426196 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-30 [patent_title] => 'Alphavirus structural protein expression cassettes' [patent_app_type] => B1 [patent_app_number] => 09/415785 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 68 [patent_no_of_words] => 71398 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/426/06426196.pdf [firstpage_image] =>[orig_patent_app_number] => 09415785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459072 [patent_doc_number] => 06391632 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis' [patent_app_type] => B1 [patent_app_number] => 09/415784 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 68 [patent_no_of_words] => 70849 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391632.pdf [firstpage_image] =>[orig_patent_app_number] => 09415784 [rel_patent_id] =>[rel_patent_doc_number] =>)